Cytokine release of whole blood from adult female donors challenged with mistletoe lectin-1 standardised mistletoe extract and E. coli endotoxin or phytohaemagglutinin (PHA)

Anticancer Res. 2003 Mar-Apr;23(2B):1349-52.

Abstract

Cytokine (TNF, alpha, interleukin-6) release of whole blood from healthy donors was challenged with mistletoe extract standardised for mistletoe lectin-1 (sML) and control substances (E. coli endotoxin; phytohaemagglutinin). The rationale of this investigation was non-proven warnings that pro-inflammatory cytokines induce by the application of standardised mistletoe lectins may induce tumor cell proliferation. These investigations provided evidence that non-cytotoxic concentrations of sML did not induced enhanced TNFa or interleukin-6 secretion compared to non-challenged control cells. Cytotoxic concentrations of sML, however, induced significantly higher cytokine levels than the control, obviously due to non-physiological stimuli. Immunomodulation with clinically relevant, low-dose sML incubation did not induce proinflammatory cytokine secretion in vitro.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Blood Cells / drug effects
  • Blood Cells / metabolism
  • Dose-Response Relationship, Drug
  • Endotoxins / pharmacology*
  • Escherichia coli
  • Female
  • Humans
  • Inflammation
  • Interleukin-6 / metabolism*
  • Lymphocytes / drug effects*
  • Lymphocytes / metabolism
  • Phytohemagglutinins / pharmacology*
  • Plant Preparations / pharmacology*
  • Plant Proteins*
  • Ribosome Inactivating Proteins, Type 2
  • Toxins, Biological / pharmacology*
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Antineoplastic Agents, Phytogenic
  • Endotoxins
  • Interleukin-6
  • Phytohemagglutinins
  • Plant Preparations
  • Plant Proteins
  • Ribosome Inactivating Proteins, Type 2
  • Toxins, Biological
  • Tumor Necrosis Factor-alpha
  • ribosome inactivating protein, Viscum